secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-05-02T23:59:59+00:00
Accession:  0001193125-23-131265
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom proposes $1.0B convertible notes due 2028; plans $250M share buyback
---------------------------------------------------------------------------

- Offering $1.0B aggregate principal of Convertible Senior Notes due 2028, with option for up to $150M additional.
- Interest semi-annual; maturity May 15, 2028; convertible upon conditions prior to Feb 2028, freely thereafter.
- Concurrent repurchase of up to $250M of common stock in privately negotiated transactions via initial purchasers.
- Net proceeds also for capital expenditures, working capital, corporate purposes, potential acquisitions.
- Plans capped call transactions to reduce dilution on conversion; cap price to be determined at pricing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523131265/0001193125-23-131265-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523131265/d462275d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-131265

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer